Table 1. HMGB1 concentrations associated with inflammatory and eosinophil-related diseases.
Disease | Reference | Body fluid | Conditions evaluated | [HMGB1] ng/mL |
---|---|---|---|---|
Vasculitis | [18] | Serum | Controls | 30 ± 16 |
Urticarial vasculitis | 51 ± 32 | |||
Allergic vasculitis | 53 ± 37 | |||
Henoch-Schonlein purpura | 57 ± 41 | |||
[27] | Serum | Controls | < 5 | |
Wegener's granulomatosis | 12 ± 9 | |||
Dermatitis | [28] | Serum | Controls | 28 ± 18 |
Psoriasis | 78 ± 66 | |||
Atopic dermatitis | 35 ± 20 | |||
Allergy/Asthma | [29] | Nasal lavage | Controls | 9 ± 4 |
Allergic rhinitis | 97 ± 19 | |||
[20] | Plasma | Controls | 3.7 | |
Eosinophilic asthma | 4.7 | |||
[20] | Sputum | Controls | 0.4 | |
Eosinophilic asthma | 3.8 | |||
Autoimmune | [30] | Serum | Controls | 13 ± 10 |
Lupus nephritis | 108 ± 48 | |||
[31] | Serum | Controls | 18 | |
Rheumatoid arthritis | 71 |